
无数据
无数据
无数据
| CAS Number | 98-96-4 |
| Catalog Number | AG003U1S(AGN-PC-07Q1HT) |
| Chemical Name | Pyrazinamide |
| EC Number | 202-717-6 |
| IUPAC Name | pyrazine-2-carboxamide |
| InChI | InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9) |
| InChI Key | IPEHBUMCGVEMRF-UHFFFAOYSA-N |
| MDL Number | MFCD00006132 |
| Molecular Formula | C5H5N3O |
| Molecular Weight | 123.1127 |
| SMILES | NC(=O)C1=CN=CC=N1 |
| UNII | 2KNI5N06TI |
| Synonyms | Pyrazinamide,
Tisamid,
pyrazinamide,
pyrazinecarboxamide,
98-96-4,
pyrazine-2-carboxamide,
pyrazinoic acid amide,
Zinamide,
2-Pyrazinecarboxamide,
Aldinamide,
Aldinamid,
Pirazinamid,
Pyrazineamide,
Pyrafat,
Tebrazid,
Unipyranamide,
Farmizina,
Pirazimida,
pyrazine carboxylamide,
Eprazin,
Novamid,
2-Carbamylpyrazine,
Pyrazinecarboxylic acid amide,
Pyrazinamidum,
Pirazinamida,
Tisamid,
Isopas,
Pirazinamide,
Pyrazine carboxamide,
Pezetamid,
Piraldina,
Braccopiral,
Corsazinmid,
Pyrazinamdie,
Dipimide,
Lynamide,
Prazina,
Pyramide,
Pyrazide,
Tebrazio,
Zinastat,
Rozide,
Pirazinamide [DCIT],
MK 56,
PZA,
D-50,
Pyrazinamidum [INN-Latin],
NCI-C01785,
Pirazinamida [INN-Spanish],
C5H5N3O,
D-50 (VAN),
UNII-2KNI5N06TI,
DRG 0124,
NSC 14911,
CCRIS 545,
HSDB 3576,
T 165,
EINECS 202-717-6,
BRN 0112306,
2KNI5N06TI,
MLS000069730,
CHEBI:45285,
Pyrazine-2-carboxylic acid amide,
IPEHBUMCGVEMRF-UHFFFAOYSA-N,
NSC14911,
Pyrazinamide (Pyrazinoic acid amide),
MFCD00006132,
Pyrazinamide, 99%,
NCGC00015833-09,
SMR000036662,
DSSTox_CID_1215,
DSSTox_RID_76014,
DSSTox_GSID_21215,
Pharozinamide,
Rifafour,
P ezetamid,
pms-Pyrazinamide,
CAS-98-96-4,
Pyrazinamide (TN),
2-carbamyl pyrazine,
Pyrazinamide [INN:BAN:JAN],
Rifafour e-200,
Pyrazinoic acid am ide,
SR-01000076077,
Pyrazinamide BP 2000,
pyrazinamida,
Pyrazinamid,
Pyrizinamide,
pyrazine amide,
AZT + Pyrazinamide combination,
Pyrazinamide,(S),
Pyrazinamide [USP:INN:BAN:JAN],
2-Carbamoylpyrazine,
Prestwick_811,
ACMC-20aive,
2-pyrazine carboxamide,
Spectrum_000902,
Opera_ID_735,
AC1L1ALT,
AC1Q4ZGM,
Prestwick0_000514,
Prestwick1_000514,
Prestwick2_000514,
Prestwick3_000514,
Spectrum2_001305,
Spectrum3_001046,
Spectrum4_001186,
Spectrum5_001026,
Lopac-P-7136,
CHEMBL614,
P 7136,
WLN: T6N DNJ BVZ,
pyrazine-2-carboximidic acid,
Lopac0_001011,
SCHEMBL24102,
BSPBio_000467,
BSPBio_002572,
KBioGR_001851,
KBioSS_001382,
5-25-04-00178 (Beilstein Handbook Reference),
KSC449E8F,
MLS002222347,
BIDD:GT0228,
DivK1c_000241,
SPECTRUM1500518,
SPBio_001369,
SPBio_002388,
BPBio1_000515,
EBD430,
GTPL7287,
ZINC2005,
DTXSID9021215,
2-pyrazinecarboxylic acid amide;,
HMS500M03,
KBio1_000241,
KBio2_001382,
KBio2_003950,
KBio2_006518,
KBio3_001792,
Pyrazinamide (JP17/USP/INN),
NINDS_000241,
BDBM228814,
HMS1569H09,
HMS1920N08,
HMS2092E09,
HMS2096H09,
HMS2235G17,
HMS3259O04,
HMS3263K03,
HMS3371G09,
HMS3655A10,
HMS3713H09,
KUC109577N,
Pharmakon1600-01500518,
Pyrazinamide(Pyrazinoic-acid-amide),
ACT01761,
HY-B0271,
KS-00000B7D,
KSC-27-052E,
Tox21_110237,
Tox21_202059,
Tox21_302771,
Tox21_501011,
ANW-75384,
BBL010592,
CCG-39243,
NSC-14911,
NSC757304,
s1762,
SBB004276,
STK801661,
AKOS000120280,
Tox21_110237_1,
CS-2260,
DB00339,
LP01011,
LS-2053,
MCULE-6846697749,
NC00534,
NSC-757304,
Pyrazinecarboxamide, analytical standard,
IDI1_000241,
NCGC00015833-01,
NCGC00015833-02,
NCGC00015833-03,
NCGC00015833-04,
NCGC00015833-05,
NCGC00015833-06,
NCGC00015833-07,
NCGC00015833-08,
NCGC00015833-10,
NCGC00015833-11,
NCGC00015833-12,
NCGC00015833-15,
NCGC00015833-16,
NCGC00090695-01,
NCGC00090695-03,
NCGC00090695-04,
NCGC00090695-05,
NCGC00090695-06,
NCGC00090695-07,
NCGC00256336-01,
NCGC00259608-01,
NCGC00261696-01,
Pyrazinoic acid amide; pyrazinamide; PZA,
AJ-08121,
AK-94813,
CAS- 98-96-4,
CPD000036662,
SAM002554927,
SC-46323,
SY013550,
TS-01626,
SBI-0050984.P004,
AB0008224,
AB2000278,
AJ-138256,
DB-002866,
ST2413707,
TR-030381,
AB00052083,
B2122,
BB 0253141,
EU-0101011,
FT-0659757,
P0633,
ST45022155,
SW196945-3,
C01956,
D00144,
J10111,
M-7421,
AB00052083-16,
AB00052083_17,
AB00052083_18,
MFCD00006132 (97+%),
AC-907/25014068,
I14-6758,
SR-01000076077-1,
SR-01000076077-4,
SR-01000076077-6,
W-100059,
Z33546644,
Pyrazinamide, British Pharmacopoeia (BP) Reference Standard,
Pyrazinamide, European Pharmacopoeia (EP) Reference Standard,
Pezetamid;Pyrafat;Zinamide;Tebrazid;Pyrafat;Pyrazinoic acid amide,
Pyrazinamide, United States Pharmacopeia (USP) Reference Standard,
InChI=1/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9,
Pyrazinamide, Pharmaceutical Secondary Standard; Certified Reference Material,
Rifater,
Pirilene,
pyramizade,
Mixture Name,
alpha-pyrazinamide,
2-pirazinecarboxamida,
1-Benzyl-1H-imidazole,
D0XF8W,
Pyrazinamide [BAN:INN:JAN],
Pyrazinamide (JP15/USP/INN),
CID1046,
C5-H5-N3-O,
1,2-dihydro-1,2,4-triazol-3-one,
ACN-038145,
CS-O-02122,
Pyrazinamide, 99% - 100G 100g,
Pyrazine-2-carboximidic acid methylester,
D011718,
4238-71-5,
Pyrazinoic acid amide, Pezetamid, Pyrafat, Zinamide, Tebrazid, Pyrafat, Pyrazinamide,
PAZ,
PYZ,
|
| Complexity | 115 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 123.043g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 9 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 123.115g/mol |
| Monoisotopic Mass | 123.043g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 68.9A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.6 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

